Key result
Periodontitis is linked to ~20% higher coronary heart disease risk, though treatment benefits remain unproven.
Why the study?
Recurrent cardiovascular events occur despite optimal secondary prevention due to residual inflammatory risk. Periodontitis is a common, treatable inflammatory disease linked to cardiovascular disease, prompting examination of periodontal health as a potential target in cardiac rehabilitation and secondary prevention.
Does periodontal treatment reduce cardiovascular events or improve functional capacity and endothelial function in cardiac patients undergoing secondary cardiovascular prevention and cardiac rehabilitation?
Does periodontal treatment reduce cardiovascular events or improve functional capacity and endothelial function in cardiac patients undergoing secondary cardiovascular prevention and cardiac rehabilitation?
Answers are grounded in this paper and cite their sources.
Periodontal health is a potentially modifiable contributor to residual inflammatory cardiovascular risk, and cardiac rehabilitation offers a suitable setting to integrate oral-systemic care and conduct definitive outcome trials.
Background/Objectives: A substantial share of recurrent cardiovascular events occurs despite optimal secondary prevention, drawing attention to residual inflammatory risk. Periodontitis, a common and treatable inflammatory disease, shares risk factors with cardiovascular disease and is linked to it through systemic inflammation and endothelial dysfunction. This review, by cardiologists and periodontists, examines periodontal health as a potential target in cardiac rehabilitation and secondary prevention. Methods: We searched PubMed/MEDLINE, Scopus, and Web of Science with predefined search strings, synthesized the evidence narratively, and graded its certainty by theme. Results: Periodontitis is consistently associated with cardiovascular disease (pooled relative risk of coronary heart disease 1.20, 95% CI 1.12–1.29), but confounding is likely and causality is unproven. Periodontal treatment improves endothelial function and some surrogate markers and appears safe in cardiac patients, including those on antithrombotic therapy, but the only secondary-prevention trial was a pilot. Cross-sectional data link periodontal status to exercise capacity, but no trial has shown that treatment reduces cardiovascular events or improves functional capacity. Conclusions: Periodontal health is best regarded as a potentially modifiable contributor to residual cardiovascular risk. Cardiac rehabilitation is a suitable setting to pilot a pathway of screening, referral, guideline-based treatment, and education, and to conduct the trials needed to establish cardiovascular benefit.
No takes yet. Share an insight, caveat, or question.
Caloian et al. (2026) conducted a review in Cardiovascular disease and periodontitis. Periodontitis / Periodontal treatment was evaluated on Coronary heart disease (RR 1.20, 95% CI 1.12-1.29). Periodontitis is consistently associated with coronary heart disease, though causality and event reduction from periodontal treatment remain unproven.
Synapse has enriched 10 related papers. Consider them for comparative context: